Literature DB >> 12570200

Inhibition of bleach-induced luminol chemiluminescence.

Erina J M Kent1, Douglas A Elliot, Gordon M Miskelly.   

Abstract

The luminol chemiluminescence presumptive test for blood is based on the mild peroxidase activity of hemoglobin in basic peroxide solution. However, this test is subject to interference by strong oxidants, certain transition metal ions, and true peroxidases. This paper reports methods for reducing the interference caused by hypochlorite-containing bleaches. Amines such as 1,2-diaminoethane react rapidly with hypochlorite without interfering significantly with the hemoglobin-catalyzed oxidation. Thus, addition of 0.1 mol/L 1,2-diaminoethane to a standard luminol-peroxide spray lead to almost complete inhibition of hypochlorite-induced chemiluminescence while satisfactory chemiluminescence was still observed from bloodstains. If time allows, an alternative method for reducing interference from hypochlorite bleach is to wait several days until the bloodstains have dried thoroughly, by which time the hypochlorite will have decomposed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12570200

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  3 in total

1.  Active oxygen doctors the evidence.

Authors:  Ana Castelló; Francesc Francès; Dolores Corella; Fernando Verdú
Journal:  Naturwissenschaften       Date:  2008-10-21

2.  MicroRNA markers for forensic body fluid identification obtained from microarray screening and quantitative RT-PCR confirmation.

Authors:  Dmitry Zubakov; Anton W M Boersma; Ying Choi; Patricia F van Kuijk; Erik A C Wiemer; Manfred Kayser
Journal:  Int J Legal Med       Date:  2010-02-10       Impact factor: 2.686

3.  Stable RNA markers for identification of blood and saliva stains revealed from whole genome expression analysis of time-wise degraded samples.

Authors:  Dmitry Zubakov; Eline Hanekamp; Mieke Kokshoorn; Wilfred van Ijcken; Manfred Kayser
Journal:  Int J Legal Med       Date:  2007-06-20       Impact factor: 2.686

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.